🟢 Oncolytics Biotech is trading 7.74% up in after-hours trading

Oncolytics Biotech is trading at $0.59, up +7.74%, with no verified October 15 after-hours announcement or specific catalyst identified.

• The broader market was mixed; available evidence does not establish a market-wide reason for the move.
• On October 14, Oncolytics reported completed GOBLET enrollment. Final Cohort 4 results are expected in Q4 2026, and initial Cohort 5 results in the first half of 2027. The update did not link to the share-price move.